These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 25802092)

  • 1. The complement system and adverse pregnancy outcomes.
    Regal JF; Gilbert JS; Burwick RM
    Mol Immunol; 2015 Sep; 67(1):56-70. PubMed ID: 25802092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation, a threat to pregnancy.
    Girardi G
    Semin Immunopathol; 2018 Jan; 40(1):103-111. PubMed ID: 28900713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for placental senescence in the genesis of obstetric complications and fetal growth restriction?
    Sultana Z; Maiti K; Dedman L; Smith R
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S762-S773. PubMed ID: 29275823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Defective Placentation and Pregnancy Loss by Blocking Innate Immune Pathways in a Syngeneic Model of Placental Insufficiency.
    Gelber SE; Brent E; Redecha P; Perino G; Tomlinson S; Davisson RL; Salmon JE
    J Immunol; 2015 Aug; 195(3):1129-38. PubMed ID: 26071558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.
    Girardi G; Yarilin D; Thurman JM; Holers VM; Salmon JE
    J Exp Med; 2006 Sep; 203(9):2165-75. PubMed ID: 16923853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement in pregnancy: a delicate balance.
    Denny KJ; Woodruff TM; Taylor SM; Callaway LK
    Am J Reprod Immunol; 2013 Jan; 69(1):3-11. PubMed ID: 22925193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation in animal and human pregnancies as a model for immunological recognition.
    Girardi G; Prohászka Z; Bulla R; Tedesco F; Scherjon S
    Mol Immunol; 2011 Aug; 48(14):1621-30. PubMed ID: 21600656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond.
    Girardi G; Lingo JJ; Fleming SD; Regal JF
    Front Immunol; 2020; 11():1681. PubMed ID: 32849586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Complement System and Preeclampsia.
    Regal JF; Burwick RM; Fleming SD
    Curr Hypertens Rep; 2017 Oct; 19(11):87. PubMed ID: 29046976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?
    Pierik E; Prins JR; van Goor H; Dekker GA; Daha MR; Seelen MAJ; Scherjon SA
    Front Immunol; 2019; 10():3098. PubMed ID: 32010144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guilty as charged: all available evidence implicates complement's role in fetal demise.
    Girardi G
    Am J Reprod Immunol; 2008 Mar; 59(3):183-92. PubMed ID: 18275511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal Chronic Villitis and Disorders of the Placental Basal Plate: A Possible Immunological Link Between Hypertensive Disorders of Pregnancy and Morbidly Adherent Placenta.
    Katzman PJ; Blitman J; Metlay LA
    Pediatr Dev Pathol; 2019; 22(4):334-339. PubMed ID: 30665335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement inhibition keeps mothers calm and avoids fetal rejection.
    Girardi G
    Immunol Invest; 2008; 37(5):645-59. PubMed ID: 18716942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement inhibition and statins prevent fetal brain cortical abnormalities in a mouse model of preterm birth.
    Pedroni SM; Gonzalez JM; Wade J; Jansen MA; Serio A; Marshall I; Lennen RJ; Girardi G
    Biochim Biophys Acta; 2014 Jan; 1842(1):107-15. PubMed ID: 24184716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of placental pathology in preterm, late-preterm, near-term, and term births.
    Stanek J
    Am J Obstet Gynecol; 2014 Mar; 210(3):234.e1-6. PubMed ID: 24145185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5.
    Qu XW; Jilling T; Neerhof MG; Luo K; Hirsch E; Thaete LG
    J Reprod Immunol; 2012 Sep; 95(1-2):27-35. PubMed ID: 22688254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.
    Cohen D; Buurma A; Goemaere NN; Girardi G; le Cessie S; Scherjon S; Bloemenkamp KW; de Heer E; Bruijn JA; Bajema IM
    J Pathol; 2011 Dec; 225(4):502-11. PubMed ID: 21688269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation: a critical mediator of adverse fetal outcomes in placental malaria?
    Conroy AL; McDonald CR; Silver KL; Liles WC; Kain KC
    Trends Parasitol; 2011 Jul; 27(7):294-9. PubMed ID: 21493146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
    Smith GC; Crossley JA; Aitken DA; Jenkins N; Lyall F; Cameron AD; Connor JM; Dobbie R
    Obstet Gynecol; 2007 Jun; 109(6):1316-24. PubMed ID: 17540803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.